Evotec - Research never stops

Archive



Mar 18, 2005

Ad hoc: Evotec OAI Announces In-licensing of a Compound

Mar 06, 2005

Ad hoc: Evotec Acquires ENS and Secures € 47m in Cash to Develop CNS Pipeline

Evotec increases focus on proprietary drug discovery and development and emphasis on cash generation in contract research

- read more